Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1)
The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years
At this level some providers switch to higher-concentration vials to keep injection volume manageable
The data suggest that GLP-1-induced weight loss includes both fat mass and lean mass reduction, with approximately 25-40% of total weight loss coming from lean tissue
Cinnamon and Chromium GLP-1 alternative patches may contain cinnamon and chromium to mimic the anti-diabetic action of these drugs
Ongoing care After enrollment, the program includes provider access, a dedicated Care Coach (per brand positioning), access to LIV Body's supplement deals, and the "Muscle Guard" nutritional strategy